KalVista Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
KalVista Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • KalVista Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending July 31, 2023 was $3.25M, a 23.2% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.9M, a 121% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.92M, a 10.5% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.1M, a 55.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.9M +$12M +121% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 $9.92M -$1.16M -10.5% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 $11.1M +$3.97M +55.7% May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 $7.12M +$2.67M +60% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 $4.45M +$1.48M +50% May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 $2.97M +$1.91M +180% May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 $1.06M +$666K +169% May 1, 2017 Apr 30, 2018 10-K 2020-07-01
2016 $394K -$391K -49.8% May 1, 2016 Apr 30, 2017 10-K 2019-07-16
2015 $785K +$404K +106% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $381K +$143K +60.1% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $238K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.